Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Three more reimbursable health apps available in Germany

In late October 2020, three more reimbursable health apps were introduced on the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM). These applications can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers.

Now besides Kalmeda and Velibra, introduced in early October 2020, three more health apps are available at the DiGA Directory: Somnio, Vivira, and Zanadio.

The Somnio (mementor DE GmbH, Germany) is a digital application for the treatment of problems related to falling asleep and staying asleep (insomnia). In the application, evidence-based and guideline-compliant content from the field of cognitive-behavioral therapy for insomnia is applied. The app is available only in German.

The Vivira (Vivira Health Lab GmbH, Germany) is a digital health application for the treatment of back, knee and hip pain in non-specific low back pain, osteoarthritis of the spine (osteochondrosis), osteoarthritis of the knee (gonarthrosis), non-specific knee pain, osteoarthritis of the hip (coxarthrosis) and non-specific hip pain via the offered movement therapy. The app is available in English and German.

The Zanadio (aidhere GmbH, Germany) is an application that helps users to reduce their weight by changing their habits in the areas of exercise, nutrition and other behavior based on the scientific concept of multimodal, conservative obesity therapy. The app is available only in German.

The statutory health insurance will fully cover the price of the apps (€464 for Somnio, €239.97 for Vivira and €499.80 for Zanadio).

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).